Pathogenicity assessment evaluates infectious agent virulence and disease-causing potential. Virulence factor identification determines pathogenic mechanisms. Animal model assessment predicts human pathogenicity. Tissue tropism determines infection targeting. Immune escape mechanisms explain pathogenic persistence.
Regulatory submissions address pathogenicity for infectious disease agents. Biomarker correlation identifies virulent strains. Therapeutic targeting of virulence factors improves outcomes. Post-approval surveillance identifies emerging pathogens. Emerging genomics characterises pathogenicity mechanisms.
General Biopharmaceutical Concepts
Pathogenicity Assessment
Pathogenicity assessment evaluates the ability of a microorganism or biological agent to cause disease and the severity of its effects.
Continue Exploring
Browse over 900 biopharmaceutical terms across biologics, ADCs, cell & gene therapy, CMC, clinical development and manufacturing.
Browse Glossary →